Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas (Q70424297)
Jump to navigation
Jump to search
scientific article published on 01 August 1982
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas |
scientific article published on 01 August 1982 |
Statements
Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas (English)
Karlin DA
Stroehlein JR
Bennetts RW
Jones RD
Heifetz LJ